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Abstract Two main entry points for electrons into the mito-
chondrial respiratory chain are NADH:ubiquinone oxidoreduc-
tase (complex I) and succinate:ubiquinone oxidoreductase (com-
plex II). Metabolic regulation of these two respiratory
complexes is not understood in detail. It has been suggested
that the Krebs cycle metabolic intermediate oxaloacetate
(OAA) inhibits complex II in vivo, whereas complex I undergoes
a reversible active/de-active transition. In normoxic and anoxic
hearts it has been shown that the proportion of complex I in the
active and de-active states is di¡erent suggesting a possible
mode of regulation of the enzyme by oxygen concentration. In
the current studies rapid isolation of mitochondrial membranes
in a state that preserves the activity of both complex I and
complex II has been achieved using Langendor¡ perfused rat
hearts. The ¢ndings indicate that the state of activation of com-
plex I is controlled by the oxygen saturation in the perfusate. In
addition, these studies show that complex II is fully active in the
mitochondrion and not inhibited by OAA regardless of the oxy-
gen concentration.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
When tissue is supplied with glucose as a primary energy
source, mitochondrial complex I (NADH:ubiquinone oxido-
reductase) and complex II (succinate:ubiquinone oxidoreduc-
tase) (succinate dehydrogenase, SDH) are two entry points
into the respiratory chain for electrons provided by operation
of the Krebs cycle. One turnover of the Krebs cycle results in
three NAD(P)H molecules and one ubiquinone molecule re-
duced by succinate. Regulation of these two enzyme activities
is important for the coupling of the Krebs cycle to the elec-
tron transport chain.
Since isolated bovine heart submitochondrial particles
(SMP) always show signi¢cant inhibition of SDH activity by
oxaloacetate (OAA), it was suggested that OAA regulates
complex II activity and the overall Krebs cycle [1,2]. It is
also known that mammalian complex I exists in equilibrium
between interchangeable active (A-) and de-active (D-) forms,
where only the A-form is capable of ubiquinone reduction by
NADH [3,4]. Recently it was shown in Langendor¡ perfused
rat hearts that modulation of normoxia/anoxia a¡ects the
complex I equilibrium from the almost fully A-form in nor-
moxia to a predominately D-form in anoxia [5]. Oxygen as a
¢nal electron acceptor controls the rate of mitochondrial res-
piration and utilization of reducing equivalents formed by
operation of the Krebs cycle. Thus, metabolic changes due
to alterations in tissue oxygenation may control the equilibri-
um of the A/D-forms of complex I and the extent of SDH
inhibition by OAA.
In the present study we used a Langendor¡ rat heart model
to ask two questions: (i) what is the relation between oxygen
level on the activation state of complex I over a wide range of
oxygen concentrations; and (ii) does OAA inhibit complex II
in vivo? To answer these questions mitochondrial membranes
were rapidly isolated from perfused rat hearts and the pro-
portion of the A/D-forms of complex I and levels of OAA
inhibition of SDH were determined. We observed that varying
the levels of oxygen in the perfusate profoundly in£uenced the
A/D ratio of complex I and found that in vivo complex II is
fully active and not inhibited by OAA.
2. Materials and methods
2.1. Langendor¡ perfused rat hearts
Male Sprague^Dawley rats (250^300 g) were anesthetized with so-
dium pentobarbital (60 mg/kg, intraperitoneal (i.p.)) and anticoagu-
lated with heparin (5000 USP units/kg, i.p.). The thorax was opened
and the heart excised and rapidly transferred to an ice-cold solution
containing 120 mM NaCl and 30 mM KCl. The heart was then
cannulated via the aorta and perfusion started within 1 min in the
Langendor¡ apparatus with a constant pressure of 70 mm Hg and
temperature of 37‡C. The perfusion solution was Krebs^Henseleit
bu¡er (118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgSO4,
1.2 mM KH2PO4, 24 mM NaHCO3, 11 mM glucose, pH 7.4) that
was vigorously bubbled with O2/CO2 (95:5, normoxia) as previously
described [6]. The heart was immersed in a temperature controlled
chamber and equilibrated for 10 min by perfusion with the above
normoxic bu¡er. Hearts were then perfused for di¡erent times with
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bu¡er saturated with varying gas mixtures that had O2/N2 ratios of
0/95, 5/90, 40/55, and 70/25 with a constant CO2 content of 5%. Oxy-
gen concentration in air-saturated bu¡er at 37‡C was taken as 19%.
At the end of the perfusion the hearts were immediately frozen in
liquid nitrogen.
2.2. Modi¢ed Keilin^Hartree mitochondrial membrane preparation
from single rat hearts
The method used has been adapted from the Keilin^Hartree prep-
aration as previously described [7,8]. Each frozen heart was powdered
in a pre-cooled (320‡C) porcelain mortar (12.5 cm diameter). The
frozen tissue was ground with 2 g of quartz sand and 10 ml of iso-
lation medium (200 mM bis-Tris^propane (BTP, pH 8.8), 0.5 mM
ethylenediamine tetraacetic acid (EDTA), 1 mM K3Fe(CN)6, and
2 mM potassium malonate) for 15 min until the frozen powder started
to melt. Sand and tissue debris were discarded after brief centrifuga-
tion for 2 min at 16 000Ug at 4‡C. The supernatant was diluted to 40
ml with the same medium and the membranes were collected by cen-
trifugation for 25 min at 48 000Ug. The membrane pellet was rinsed
with 20 mM Tris^HCl (pH 8.0), 0.2 mM EDTA, 1 mg/ml bovine
serum albumin (BSA), and resuspended in 1 ml of the same bu¡er.
The membranes were then frozen in liquid nitrogen and stored at
380‡C until use.
2.3. Activation state of complex I
Activation state was determined spectrophotometrically at 25‡C by
comparing the NADH oxidase activity of isolated membranes to the
same sample in which complex I was fully activated [5]. Activity of
each isolated sample (20 Wg protein/ml) was assayed in 0.2 M BTP
(pH 8.8), 1 mg/ml BSA, 5 mM CaCl2. Complete activation of complex
I was achieved by preincubation of the sample (20 Wg protein/ml) in
0.1 ml of 2 mM BTP (pH 6.8) with 100 WM NADH for 2 min prior to
the addition of 0.9 ml of 0.2 M BTP (pH 8.8), 1 mg/ml BSA with 5.5
mM CaCl2 and initiation of the reaction with 150 WM NADH
(O340 = 6.22 mM31 cm31).
2.4. Inhibition of complex II by OAA
Complex II activity was determined at 25‡C by comparison of iso-
lated membranes to the same sample with OAA-free complex II.
Activity of isolated membranes (5 Wg/ml) was assayed in 50 mM
BTP (pH 8.0), 0.2 mM EDTA, 1 mM phenazine ethosulfate (PES),
50 WM dichloro-phenolindophenol (DCIP) (O600 = 21.8 mM31 cm31)
with 20 mM succinate. The initial rate of the reaction after addition of
the membranes was calculated. To completely remove OAA from the
active site of complex II, membranes (5 mg/ml) were incubated with
1 mM malonate for 20 min at 30‡C and then assayed in the above
bu¡er. Succinate oxidase activity was determined by oxygen consump-
tion using an oxygraph equipped with a Clark type electrode.
2.5. Other assays
NADH^K3Fe(CN)6 reductase [3] and NADH:Q1 reductase activ-
ities [5] of complex I were assayed as previously described. Horse
heart cytochrome c was used to stimulate NADH oxidase activity.
Protein concentration was determined by the Biuret method.
3. Results
Initially a protocol was designed and tested for preparation
of mitochondrial membranes that would simultaneously pre-
serve the activation status of complex I and permit measure of
OAA-induced inhibition of complex II during heart perfusion.
The membrane preparation was judged to be free of intact
mitochondria by treating the preparation with the channel-
forming antibiotic alamethicin [9] as intact mitochondria are
impermeable to NADH. No change in NADH oxidase activ-
ity was found whether or not alamethicin was present (data
not shown). The kinetic properties of the membrane prepara-
tion are summarized in Table 1. It is known that interconver-
sion between the A- and D-forms of complex I is extremely
temperature dependent [4]. Deactivation (A to D transition) is
a spontaneous process which occurs within minutes at 37‡C
and hours at 4‡C [4]. Activation (D to A transition) requires
reduction of the D-form by NADH followed by oxidation by
quinone [3,4]. This process occurs within tens of seconds at
37‡C but takes minutes at 4‡C. In the case of complex II,
release of OAA from the enzyme is also highly temperature
dependent and occurs within minutes at 37‡C but takes hours
at 4‡C [1]. Since temperature is such an important factor in
preserving the activation state of complex I and the OAA-
induced inhibition of complex II, a temperature of 0^2‡C
was maintained throughout the isolation procedure (Section
2). Additional considerations taken into account in designing
the protocol are as follows. Activation of complex I was sup-
pressed by raising the pH of the isolation medium to 8.8, a
condition known to inhibit activation [10]. To eliminate
NADH from the homogenate and completely block activa-
tion, 1 mM potassium ferricyanide which causes fast oxida-
tion of NADH was included in the isolation medium. The
NADH^ferricyanide reductase reaction is temperature inde-
pendent (V4 kJ/mol) whereas the NADH oxidase activity is
highly temperature dependent (V65 kJ/mol). Thus at the low
temperature (0^2‡C) used for isolation of membranes the
NADH dehydrogenase fragment of complex I would be
largely responsible for NADH oxidation, minimizing the pos-
sibility that complex I could be activated through the distal
portion of the respiratory chain. To protect complex II from
binding OAA during SMP isolation, malonate was added to
the isolation medium. Malonate reversibly binds to complex
II and at mM concentration prevents OAA binding to the
enzyme in the homogenate [1,2].
Table 2 shows the NADH oxidase and SDH activity of
mitochondrial membranes isolated from perfused rat hearts.
When hearts were perfused with normoxic bu¡er (95% O2) for
30 min 95% of complex I was in the A-form and complex II
was fully active, i.e. in the OAA-free form. Anoxic perfusion
for 15 min drastically decreased the proportion of the A-form
of complex I to about 28%. When this was followed by nor-
moxic perfusion, however, complex I activity was restored to
about 85%, con¢rming that A/D transitions are reversible in
ex vivo conditions consistent with previous observations [5].
By contrast, no change in SDH activities was evident in the
membrane samples after 15 and 30 min of anoxic perfusion.
Incubation of the membranes with malonate did not increase
SDH activity indicating that the enzyme existed completely in
the OAA-free form. Membranes from a control heart, freshly
taken from the rat, contained a completely active complex I
and complex II, in agreement with the data obtained during
Table 1
Catalytic properties of Keilin^Hartree membranes isolated from rat
heart
Assay Activity, Wmol/min/mg proteina
NADH oxidase 0.42
+cyt c (10 WM) 0.64
+rotenone (5 WM) 0
NADH:Q1 reductaseb 0.4
+rotenone (5 WM) 0.01
NADH^ferricyanide (2e) 2.6
Succinate^PES^DCIP 0.22
aThe assay conditions were 50 mM BTP (pH 8.0), 0.2 mM EDTA,
1 mg/ml BSA, temperature was 25‡C. + indicates addition of horse
heart cytochrome c or rotenone to stimulate or inhibit activity re-
spectively.
bActivity was measured with 50 WM Q1 in the presence of 2 mM
potassium cyanide.
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normoxic perfusion. However, when 2 mM malonate was
omitted from the isolation medium, about 75% of the initial
rate of SDH was inhibited which could be subsequently reac-
tivated upon incubation with malonate at 30‡C. This indicates
that OAA inhibition of SDH routinely occurs during mem-
brane isolation unless malonate is supplied. Thus, metabolic
changes caused by anoxic perfusion and changing the A/D
complex I equilibrium do not a¡ect SDH inhibition by OAA.
Since anoxic perfusion caused a dramatic decrease in the
activation state of complex I the question remained whether
di¡erent oxygen concentrations during heart perfusion would
result in di¡erent steady-state levels between the A- and D-
forms. The steady-state levels of the A/D equilibrium in rat
hearts perfused with N2 (Table 2) and air-saturated bu¡er
(data not shown) were established by 30 min of perfusion.
Fig. 1 shows the e¡ect of 30 min perfusion at di¡erent levels
of oxygen saturation on the steady-state levels of the A-form
of complex I. A steep rise in the proportion of the A-form of
complex I was observed (from 18 to 75%) when the oxygen
saturation was increased to 40%. At higher than 70% oxygen
saturation complex I was found to be almost completely in its
A-form. The level of the A-form of complex I in membrane
preparations obtained from hearts after 60 min of anoxic
perfusion was 16%. However, these membranes when incubat-
ed for 10 min at 37‡C become completely deactivated (data
not shown). This observation raises the question whether the
residual amount of A-form is due to uncontrolled oxygen
contamination of the perfusion system. To test this possibility,
the hearts were perfused anaerobically in the presence of 2 mM
KCN to completely block the respiratory chain. Fig. 2 shows
that there is no di¡erence in the activation state of complex I
after the perfusion of hearts with or without KCN, indicating
that oxygen contamination is not the reason for the residual
amount of the A-form of complex I.
In this study it has been found that complex II remained
OAA-free regardless of the level of oxygenation. Mammalian
complex II is capable of catalyzing the quinol:fumarate re-
ductase reaction [11], thus allowing an alternative pathway for
quinol reoxidation. Indeed, when 2 mM fumarate was intro-
duced into the anoxic perfusion bu¡er, the steady-state level
Table 2
Activation status of complex I and OAA inhibition of complex II in perfused rat heartsa
Samples Complex I A-form (%) SDH OAA-free enzyme (%)
30 min normoxic perfusion 95S 0.5 100
15 min anoxic perfusion 28S 1.5 100
+20 min normoxic perfusion 85S 2.5 100
30 min anoxic perfusion 18S 2 100
60 min anoxic perfusion 16S 2 100
Control heartb
2 mM malonate in isolation medium 100S1.5 100
no malonate in isolation medium 100S1.5 25S 3
aThe perfusion, membrane isolation, and assay are described in Section 2. Each data point is expressed as a mean from three separate experi-
ments.
bActivity in mitochondrial membranes from freshly isolated rat heart. 100% activity corresponds to 0.42 and 0.22 Wmol/min per mg protein for
the NADH oxidase and SDH reactions, respectively.
Fig. 1. A-form complex I equilibrium established during 30 min of
perfusion with di¡erent oxygen saturation in the perfusate. Perfu-
sion conditions, membrane isolation, and enzyme assay are de-
scribed in Section 2. Fully active NADH oxidase activity corre-
sponds to 0.6 Wmol NADH per min per mg protein. Each data
point is a mean of three separate independent experiments.
Fig. 2. E¡ect of KCN, fumarate, and malonate on the A-form com-
plex I equilibrium established during 30 min of anoxic perfusion.
The concentrations of KCN, fumarate, and malonate added to the
perfusate are indicated on the ¢gure. Perfusion conditions, mem-
brane isolation, and enzyme assay conditions are described in Sec-
tion 2. Each bar represents a mean of three to four separate inde-
pendent experiments.
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of the A-form of complex I increased to 28% (Fig. 2). To
determine if quinol:fumarate reductase activity of complex
II may be responsible for the residual levels of the A-form
of complex I during anoxic perfusion with glucose, anoxic
perfusion with 2 mM malonate was performed. However, as
seen in Fig. 2, malonate had no e¡ect on the A/D equilibrium
of complex I.
4. Discussion
Complexes I and II in perfused rat hearts responded di¡er-
ently to hypoxia. While oxygen controlled the steady-state
levels of the A-form of complex I during heart perfusion,
complex II remained in an OAA-free form regardless of the
oxygen content of the perfusate. Earlier experiments with bo-
vine SMP suggested that the decrease of NADH oxidation by
the respiratory chain resulted in a lower steady-state level of
the A-form of complex I [12]. This is in agreement with the
data presented here, where variation of the levels of oxygen
saturation used during rat heart perfusion controlled the acti-
vation state of complex I. Complex I was completely in the
A-form during normoxia and lowering the oxygen saturation
in the perfusate resulted in a decrease of steady-state levels of
active complex I to about 20%.
The data in Table 2 show that complex II appears to be in
the OAA-free form after either prolonged normoxic or anoxic
perfusion. During normoxic metabolism with glucose as a
primary energy source the intramitochondrial OAA concen-
tration is believed to be very low, as thermodynamics would
poise OAA for citrate synthesis. Anoxia causes inhibition of
NADH oxidation which results in a signi¢cant increase of
mitochondrial NADH [13]. Increased concentration of
NADH is a situation where reversal of malate dehydrogenase
activity is thermodynamically favored which would also re-
duce OAA levels in the mitochondrion. Moreover, hypoxia
should cause signi¢cant reduction of the quinone pool. Redox
equilibration of the quinol pool with SDH resulted in more
than a 10-fold increase in the dissociation for OAA with re-
duced SDH [14]. The experimental protocol used to isolate
membranes in the current studies suggests that OAA-inhibited
SDH is likely due to OAA binding during the isolation pro-
cedure and is not characteristic of the state of activation of
complex II in the intact mitochondrion.
These studies have also shown that the residual 20% of the
A-form of complex I found in isolated membranes after pro-
longed anoxic perfusion of rat hearts can be fully deactivated
by incubation of membranes at 37‡C. The question remains
therefore as to why complex I can not be completely deacti-
vated in the whole organ. The possibility of an oxygen leak
contaminating the perfusion system can be discounted since
KCN did not a¡ect the residual portion of the A-form of
complex I. The signi¢cant improvements in membrane isola-
tion by modi¢cation of the Keilin^Hartree preparation allow
one to follow the activation state of complex I in the mem-
branes in parallel to the actual A/D equilibrium that occurs in
perfused hearts. As the rate of quinol reoxidation through the
respiratory chain determines the A/D equilibrium of complex
I [12], it can be hypothesized that alternative pathways for
quinol reoxidation may also a¡ect the activation state of com-
plex I.
Another result of this study is the ¢nding that complex II
remains fully active during anoxia. High levels of ubiquinol
and the availability of fumarate may allow the quinol^fuma-
rate reductase reaction under anoxic conditions. Indeed, an-
oxic perfusion with fumarate shifted the A/D complex I equi-
librium from 18 to 28% of A-form. This is the same level as
that occurred during perfusion with 5% oxygen. These data
correlate with observations that SDH shows low rates of fu-
marate reduction [11]. To understand whether the anoxic A/D
equilibrium is a result of the NADH^fumarate reductase re-
action in tissue supplied with glucose, anoxic perfusion with
malonate was performed. Even though malonate did not de-
crease the A/D equilibrium, one cannot completely exclude
the possibility of NADH^fumarate reductase activity under
anaerobic conditions as SDH is less sensitive to dicarboxylate
inhibitors when reduced. Another possible alternative path-
way for quinol oxidation may include reversible operation
of mitochondrial glycerol-3-phosphate dehydrogenase, an en-
zyme in the inner mitochondrial membrane that oxidizes glyc-
erol-3-phosphate in the cytoplasm and reduces the quinone
pool in the mitochondrial membrane. Finally, we can not
exclude the presence of other e¡ectors in intact cells that
may modulate the A/D equilibrium.
Several experimental observations suggest that complex I is
a prime source for superoxide production from the respiratory
chain [15,16] especially when a quinone site inhibitor such as
rotenone is present [17,18]. The D-form of complex I func-
tionally resembles the A-form when the latter is blocked with
rotenone as the D-form is reduced by NADH and able to
interact with di¡erent acceptors [10]. Anoxia resulted in an
increased fraction of the D-form and a decrease of the A-
form (Table 2). It is presumed that the ¢rst minutes of reoxy-
genation are the most damaging to the heart following periods
of ischemia. During this period the remaining A-form of com-
plex I would supply the respiratory chain with reducing equiv-
alents, while activation of the D-form is not instantaneous
and takes several minutes in the Langendor¡ rat model [5].
It seems possible that although complex I remains in the de-
active state during the initial period of oxygen reperfusion, de-
active complex I may contribute to increased levels of super-
oxide production and subsequent cardiac damage.
In summary the data presented here suggest that when a rat
heart is supplied with highly oxygenated arterial blood com-
plex I is fully active. However, the data also show that the
activation status of complex I is determined by oxygen con-
centration over a wide range of saturations. Since the A/D
phenomenology of complex I is not tissue speci¢c [19], other
organs such as liver can also become signi¢cantly hypoxic. In
such instances di¡erent steady-state A/D complex I equilibria
may be established in various tissues.
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